Presence and function of SARS-CoV-2-specific T-cells in recovered patients and healthy volunteers
محفوظ في:
مؤلفون آخرون: | |
---|---|
التنسيق: | الكتروني سمعي |
اللغة: | English |
منشور في: |
London :
Henry Stewart Talks,
2020.
|
سلاسل: | Henry Stewart talks. Biomedical & life sciences collection. Interviews on Covid-19.
|
الموضوعات: | |
الوصول للمادة أونلاين: | https://hstalks.com/bs/4416/ Series |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
MARC
LEADER | 00000nim a2200000 a 4500 | ||
---|---|---|---|
001 | HST8193 | ||
003 | UkLoHST | ||
006 | m o h | ||
007 | cr nna|||||||| | ||
007 | sr |mnnnnnzne| | ||
008 | 201004s2020 enk|||||o||h||||||||eng d | ||
028 | 5 | 0 | |a 8193 |b Henry Stewart Talks |
035 | |a (UkLoHST)4416 | ||
040 | |a UkLoHST |b eng |c UkLoHST | ||
100 | 1 | |a Le Bert, Nina, |u (DUKE-NUS Medical School, Singapore) |4 spk |9 88165 | |
245 | 1 | 0 | |a Presence and function of SARS-CoV-2-specific T-cells in recovered patients and healthy volunteers |h [electronic resource] / |c an interview with Nina Le Bert. |
260 | |a London : |b Henry Stewart Talks, |c 2020. | ||
300 | |a 1 online resource (1 streaming audio file (9 min.)). | ||
490 | 1 | |a Interviews on Covid-19, |x 2056-452X | |
500 | |a Audio interview. | ||
500 | |a Title from title frames. | ||
505 | 0 | |a Contents: The need to characterise SARS-CoV-2-specific T-cells from recovered patients -- Discovery of similar SARS-CoV-2-specific T-cells in healthy volunteers -- Possible reasons for presence of SARS-2-specific T-cells in healthy volunteers -- Differences in actions and behaviours of SARS-2-specific T-cells in patients versus volunteers -- Role of SARS-2-specific T-cells in conferring pre-existing immunity to COVID-19 (i.e. asymptomatic infections) -- Possible implications of the presence of such cells on disease progression -- Implications for vaccine development. | |
506 | |a Access restricted to subscribers. | ||
538 | |a Mode of access: World Wide Web. | ||
650 | 0 | |a Coronavirus infections |x Immunological aspects. |9 88166 | |
650 | 0 | |a COVID-19 (Disease) |x Research. |9 88167 | |
650 | 0 | |a COVID-19 Pandemic, 2020- |9 88168 | |
650 | 0 | |a T cells. |9 88169 | |
650 | 2 | |a Asymptomatic Infections. |9 88170 | |
650 | 2 | |a Coronavirus Infections. |9 88171 | |
650 | 2 | |a COVID-19 |x immunology. |9 88172 | |
650 | 2 | |a COVID-19 |x virology. |9 88173 | |
650 | 2 | |a Disease Progression. |9 88174 | |
650 | 2 | |a Healthy Volunteers. |9 88175 | |
650 | 2 | |a Pandemics. |9 88176 | |
650 | 2 | |a Pneumonia, Viral |x immunology. |9 88177 | |
650 | 2 | |a SARS-CoV-2. |9 88178 | |
650 | 2 | |a T-Lymphocytes |x immunology. |9 88179 | |
830 | 0 | |a Henry Stewart talks. |p Biomedical & life sciences collection. |p Interviews on Covid-19. |9 88180 | |
856 | 4 | 0 | |u https://hstalks.com/bs/4416/ |
856 | 4 | 2 | |u https://hstalks.com/bs/p/1060/ |3 Series |
999 | |c 213945 |d 213944 |